James StanselExecutive Vice President, General Counsel and Corporate Secretary at PhRMASpeaker
Profile
James Stansel is General Counsel of the Pharmaceutical Research and Manufacturers of America (PhRMA), where he is responsible for leading a team of lawyers in supporting PhRMA’s policy, advocacy and science priorities and in the development of sound legal policies impacting the pharmaceutical industry. Jim previously served as Acting General Counsel, Deputy General Counsel and Health Policy Counselor to the Secretary of the U.S. Department of Health & Human Services. He also was previously a partner and co-head of Sidley Austin LLP’s Global Life Sciences Team. Jim is a graduate of Brigham Young University and Yale Law School.
Agenda Sessions
PhRMA’s View on the Impact of Price Controls on Company R&D and Innovation
, 2:20pmView Session